Trials / Conditions / Stage IIIC Intraocular Melanoma
Stage IIIC Intraocular Melanoma
3 registered clinical trials studyying Stage IIIC Intraocular Melanoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma NCT02068586 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 |
| Terminated | Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery NCT01533948 | Roswell Park Cancer Institute | Phase 2 |
| Completed | Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma NCT00085189 | University of Southern California | Phase 2 |